RxDoctor Payments Data

Vijay Sankaran

Pediatric Hematology-Oncology · Boston, MANPI 1386969855

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (54.1%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 4 manufacturers reported payments, led by Vertex at 47.2% of the total. 2025 is the largest year on record at $3,713, 3.7 times the $1,000 reported in 2020.

$6,167in general payments, 2019–2025

Across 11 payments — averaging $560.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vertex$3K
  • GSK$2K
  • Agios Pharmaceuticals, Inc.$1K
  • Genentech, Inc.$500
$551,304in research payments, 2019–2025

Across 5 payments — averaging $110,261 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Vertex$551K

What the payments were for

  • Consulting fees$2,60042%
  • Speaking & faculty fees$3,33554%
  • Travel & lodging$781%
  • Food & beverage$1542%

General payments by program year

20
21
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Vertex2$2,913
GSK7$1,754
Agios Pharmaceuticals, Inc.1$1,000
Genentech, Inc.1$500

How this compares

$6,167 in reported general payments places this provider in the 65th percentile of 114 pediatric hematology-oncology providers in Massachusetts.

See all pediatric hematology-oncology providers in Massachusetts

Other pediatric hematology-oncology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →